F-group (family)
1075.5.1.1 MatE
Ligands and drugs
1,125
Member domains
71
with ligand contacts (≤ 4 Å)
6.3% of members
49
with DrugDomain annotations
4.4% of members
9
with a DrugBank compound
0.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 1075.5.1.1 belongs to X-group 1075 Type II ABC exporter transmembrane domain fold, which binds 8.7 ligand superclasses per 20 proteins, broader than 72% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03825 | RHQ | Rhodamine 6G | 3 |
| DB17031 | ET | Homidium | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 28 |
| CLR | CHOLESTEROL | 8 |
| CSmetal | CESIUM ION | 8 |
| CXE | PENTAETHYLENE GLYCOL MONODECYL ETHER | 8 |
| 4YH | (2S)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile | 4 |
| CL | CHLORIDE ION | 3 |
| RBmetal | RUBIDIUM ION | 3 |
| RHQ | RHODAMINE 6G | 3 |
| DM2 | DOXORUBICIN | 2 |
| ET | ETHIDIUM | 2 |
| P4P | TETRAPHENYLPHOSPHONIUM | 2 |
| SD9 | Cimetidine | 2 |
| WRF | 1-methyl-4-phenylpyridin-1-ium | 2 |
| BNU | 6-bromo-1-ethyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 1 |
| MF8 | Metformin | 1 |